Gregory M. Lucas

Gregory M. Lucas

Infectious Disease

1717 East Monument Street, Park Building, Ground Level
Park Building, Ground Level
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 141 publications

Characterizing the Geography of Drug Use Networks and Behaviors Among People Who Inject Drugs in the Baltimore Metropolitan Region.

Characterizing the Geography of Drug Use Networks and Behaviors Among People Who Inject Drugs in the Baltimore Metropolitan Region.

Journal: AIDS and behavior

Published: June 24, 2026

A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C Trial.

A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C Trial.

Journal: Journal of hepatology

Published: March 18, 2026

Evaluating Spatially Targeted HIV Interventions and Harm Reduction Services Among People Who Inject Drugs in a High-Burden Setting.

Evaluating Spatially Targeted HIV Interventions and Harm Reduction Services Among People Who Inject Drugs in a High-Burden Setting.

Journal: medRxiv : the preprint server for health sciences

Published: February 23, 2026

Characterizing the impact of the COVID-19 pandemic on HIV testing among Medicaid beneficiaries.

Characterizing the impact of the COVID-19 pandemic on HIV testing among Medicaid beneficiaries.

Journal: medRxiv : the preprint server for health sciences

Published: February 23, 2026

Comparative Effectiveness of ACE Inhibitors and Angiotensin Receptor Blockers for Cardiovascular Disease Prevention in People Living with HIV and Hypertension.

Comparative Effectiveness of ACE Inhibitors and Angiotensin Receptor Blockers for Cardiovascular Disease Prevention in People Living with HIV and Hypertension.

Journal: medRxiv : the preprint server for health sciences

Published: February 06, 2026

Increasing Syphilis Prevalence Among MSM Across India Despite Improvements in the HIV Care Continuum.

Increasing Syphilis Prevalence Among MSM Across India Despite Improvements in the HIV Care Continuum.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: November 21, 2025

Acceptability and Preferences of Long-Acting Injectable Pre-Exposure Prophylaxis and Antiretroviral Therapy Among Men Who Have Sex With Men and People Who Inject Drugs in India: Insights for Future Implementation.

Acceptability and Preferences of Long-Acting Injectable Pre-Exposure Prophylaxis and Antiretroviral Therapy Among Men Who Have Sex With Men and People Who Inject Drugs in India: Insights for Future Implementation.

Journal: Journal of the International AIDS Society

Published: July 24, 2025

Evaluating spatially targeted HIV interventions and harm reduction services among people who inject drugs in a high-burden setting.

Evaluating spatially targeted HIV interventions and harm reduction services among people who inject drugs in a high-burden setting.

Journal: Nature communications

Published: July 20, 2025

Hospital readmissions among adults with chronic kidney disease by HIV status in the United States.

Hospital readmissions among adults with chronic kidney disease by HIV status in the United States.

Journal: AIDS (London, England)

Published: April 28, 2025

Geometric deep learning enables high-fidelity network imputation for HIV transmission modeling.

Geometric deep learning enables high-fidelity network imputation for HIV transmission modeling.

Journal: Communications medicine

Published: April 10, 2025

Characterizing non-fatal overdose among people who inject drugs in India: prevalence and risk factor analysis, 2022-2024.

Characterizing non-fatal overdose among people who inject drugs in India: prevalence and risk factor analysis, 2022-2024.

Journal: The International journal on drug policy

Published: April 02, 2025

People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapy.

People who inject drugs and men who have sex with men living with HIV in India experience low probability of viral rebound and high levels of persistent viremia during the first 12 months of antiretroviral therapy.

Journal: AIDS care

Published: March 28, 2025

Showing 1-12 of 141

Last Updated: 09/26/2026